NO974255D0 - Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner - Google Patents

Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner

Info

Publication number
NO974255D0
NO974255D0 NO974255A NO974255A NO974255D0 NO 974255 D0 NO974255 D0 NO 974255D0 NO 974255 A NO974255 A NO 974255A NO 974255 A NO974255 A NO 974255A NO 974255 D0 NO974255 D0 NO 974255D0
Authority
NO
Norway
Prior art keywords
perimenopausal
useful
once
preparation
replacement therapy
Prior art date
Application number
NO974255A
Other languages
English (en)
Other versions
NO974255L (no
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974255D0 publication Critical patent/NO974255D0/no
Publication of NO974255L publication Critical patent/NO974255L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO974255A 1995-03-16 1997-09-15 Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner NO974255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
PCT/EP1996/001201 WO1996028165A1 (de) 1995-03-16 1996-03-15 Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen

Publications (2)

Publication Number Publication Date
NO974255D0 true NO974255D0 (no) 1997-09-15
NO974255L NO974255L (no) 1997-11-14

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974255A NO974255L (no) 1995-03-16 1997-09-15 Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner

Country Status (17)

Country Link
EP (1) EP0814811A1 (no)
JP (1) JPH11501649A (no)
KR (1) KR19980703058A (no)
AR (1) AR002283A1 (no)
AU (1) AU713258B2 (no)
CA (1) CA2215382A1 (no)
CZ (1) CZ289697A3 (no)
DE (1) DE19510861A1 (no)
HU (1) HUP9801691A3 (no)
IL (1) IL117516A (no)
MX (1) MX9707009A (no)
NO (1) NO974255L (no)
NZ (1) NZ304027A (no)
PL (1) PL322202A1 (no)
SK (1) SK123997A3 (no)
WO (1) WO1996028165A1 (no)
ZA (1) ZA962177B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
HUP9801691A3 (en) 1999-03-01
IL117516A (en) 2000-07-26
JPH11501649A (ja) 1999-02-09
KR19980703058A (ko) 1998-09-05
NO974255L (no) 1997-11-14
CA2215382A1 (en) 1996-09-19
EP0814811A1 (de) 1998-01-07
AU5110896A (en) 1996-10-02
HUP9801691A2 (hu) 1998-11-30
ZA962177B (en) 1996-07-29
SK123997A3 (en) 1998-02-04
AU713258B2 (en) 1999-11-25
NZ304027A (en) 2000-05-26
CZ289697A3 (en) 1997-12-17
PL322202A1 (en) 1998-01-19
IL117516A0 (en) 1996-07-23
AR002283A1 (es) 1998-03-11
DE19510861A1 (de) 1996-09-19
MX9707009A (es) 1997-11-29
WO1996028165A1 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
NO960373D0 (no) Stabilisert farmasöytisk preparat inneholdende bupropion
DE69923200D1 (de) Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
BR9408513A (pt) Agente e método para a contracepçÃo hormonal e/ou para o tratamento de acne
IL103594A (en) Compositions comprising a tramadol material and a nonsteroidal antiinflammatory drug
AU1929495A (en) Mobility management method for delivering calls in a microcellular network
NO986104L (no) Progesteron-anti-progesteron regimer
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
MX9203319A (es) Metodo para la preparacion de cristales de alfa-2 interferona.
AU682166B2 (en) Synergising association having an antagonist effect on NK1 and NK2 receptors
AU5591296A (en) N-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl)benzamide derivatives, their preparation and their application in therapeutics
NO974255D0 (no) Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
NO985807L (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
ITMI920425U1 (it) Copertura estensibile per imbottiti, in particolare per divani e poltrone.
UA43337C2 (uk) Гормональний засіб для лікування вугрів
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.
Tanzer Small is beautiful
ITPR930023V0 (it) Cilindro per fonditrice a depressione, in particolare per uso odonto- tecnico.
ES1028324Y (es) Funda elastica perfeccionada para sofas y sillones.
BR1100177A (pt) Composição sinérgica para despigmentação da pele.
GT199400048A (es) Composicion farmaceutica y proceso para su preparacion
IE881739L (en) Emulsifying agent, for cement and use
CO4180403A1 (es) Aparato y metodo de enfriamiento de moldes para maquina for- madora de articulos de vidrio.
ES1032069Y (es) Mesa para hosteleria y similar
BR9303578A (pt) Método para a administração de um antiandrogeno através da pele, e composição farmacêutica antiandrogênica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application